- Home
- GERN vs GSL Comparison
GERN vs GSL Comparison
Compare GERN & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- GSL
- Stock Information
- Founded
- GERN 1990
- GSL 2007
- Country
- GERN United States
- GSL Greece
- Employees
- GERN N/A
- GSL N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- GSL Marine Transportation
- Sector
- GERN Health Care
- GSL Consumer Discretionary
- Exchange
- GERN Nasdaq
- GSL Nasdaq
- Market Cap
- GERN 840.7M
- GSL 758.7M
- IPO Year
- GERN 1996
- GSL 2006
- Fundamental
- Price
- GERN $1.18
- GSL $22.09
- Analyst Decision
- GERN Buy
- GSL Strong Buy
- Analyst Count
- GERN 9
- GSL 1
- Target Price
- GERN $5.13
- GSL $29.00
- AVG Volume (30 Days)
- GERN 11.5M
- GSL 266.8K
- Earning Date
- GERN 05-07-2025
- GSL 05-19-2025
- Dividend Yield
- GERN N/A
- GSL 8.16%
- EPS Growth
- GERN N/A
- GSL 17.78
- EPS
- GERN N/A
- GSL 9.67
- Revenue
- GERN $116,293,000.00
- GSL $705,529,000.00
- Revenue This Year
- GERN $194.54
- GSL $1.84
- Revenue Next Year
- GERN $56.51
- GSL N/A
- P/E Ratio
- GERN N/A
- GSL $2.28
- Revenue Growth
- GERN 22264.04
- GSL 5.82
- 52 Week Low
- GERN $1.17
- GSL $17.73
- 52 Week High
- GERN $5.34
- GSL $30.32
- Technical
- Relative Strength Index (RSI)
- GERN 32.46
- GSL 58.00
- Support Level
- GERN $1.34
- GSL $21.26
- Resistance Level
- GERN $1.44
- GSL $22.23
- Average True Range (ATR)
- GERN 0.10
- GSL 0.49
- MACD
- GERN 0.00
- GSL 0.18
- Stochastic Oscillator
- GERN 3.23
- GSL 94.31
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.